Shake Shack Inc.
—- Market cap
- —
- Debt
- +$247.73M
- Cash
- −$360.12M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SHAK stock price vs OPK: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OPK's multiple
Needs OPK P/E.
Implied fair value · at SHAK's multiple
Needs Annual EPS is negative, SHAK P/E.
Metric by metric
Where each company leads, and how wide the gap is.
Price unavailable
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SHAK FY 2025 (ended Dec 31, 2025) · OPK FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SHAKE SHACK INC. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
OPKO Health, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.47x
0.54x
Net debt / EBITDA
Leverage against operating earnings
-0.62x
-3.03x
Cash and equivalents
Liquid reserves on the balance sheet
$360.12M
$364.41M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CHIPOTLE MEXICAN GRILL INC
SHAK vs CMG
YUM BRANDS INC
SHAK vs YUM
MCDONALDS CORP
SHAK vs MCD
DARDEN RESTAURANTS INC
SHAK vs DRI
Bloomin' Brands, Inc.
SHAK vs BLMN
AMARIN CORP PLC\UK
SHAK vs AMRN
Sarepta Therapeutics, Inc.
SHAK vs SRPT
Amphastar Pharmaceuticals, Inc.
SHAK vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
SHAK vs SUPN
Harmony Biosciences Holdings, Inc.
SHAK vs HRMY
$247.73M
$687.93M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.